The relationship between BRAFV600E, NF-κB and TgAb expression in papillary thyroid carcinoma
Authors:
- 1 March 2017
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 213 (3) , 183-188
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81301244)
This publication has 23 references indexed in Scilit:
- Strong immunoexpression of midkine is associated with multiple lymph node metastases in BRAFV600E papillary thyroid carcinomaHuman Pathology, 2015
- Papillary Thyroid Cancer and Hashimoto’s Thyroiditis: An Association Less UnderstoodIndian Journal of Surgical Oncology, 2014
- Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin AutoantibodiesThyroid®, 2014
- Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid CarcinomaThyroid®, 2014
- The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid CancersThyroid®, 2013
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid CarcinomaClinical Cancer Research, 2009
- Inhibition of Raf-1 Alters Multiple Downstream Pathways to Induce Pancreatic β-Cell ApoptosisJournal of Biological Chemistry, 2008
- Pathologic features of Hashimoto's-associated papillary thyroid carcinomasHuman Pathology, 2001
- Significance of Antithyroglobulin Autoantibodies in Differentiated Thyroid CarcinomaThyroid®, 1994